Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models?

被引:44
作者
Renard, C [1 ]
Van Obberghen, E [1 ]
机构
[1] INSERM, U145, Fac Med, F-06107 Nice, France
关键词
diabetes; atherosclerosis; animal models; macrovascular complications; dyslipidemia;
D O I
10.1016/S1262-3636(07)70243-4
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Diabetes mellitus is associated with a greater risk of developing atherosclerosis and its complications: stroke, myocardial infarction, and peripheral vascular disease. In patients with diabetes, atherosclerosis represents a complex multifactorial disease with increased lesion progression and severity compared to the nondiabetic population. Several risk factors have been proposed to explain the increased risk of cardiovascular disease with diabetes. They include: hyperglycaemia, dyslipidemia, accelerated formation of advanced glycation end-products (AGEs), increased oxidative stress, and genetic factors. It is difficult to precisely establish the elements leading to diabetes-accelerated atherosclerosis by means of epidemiological studies because all these factors coexist in diabetic patients. Thus, diabetic animal models that reproduce exacerbation of atherosclerosis would be helpful to understand why atherosclerosis is accelerated by diabetes, and to design appropriate treatments to limit its progression. This review analyzes most of the animal models developed to reproduce diabetes-accelerated atherosclerosis, and summarizes the effects of hyperglycaemia and lipid abnormalities on atherogenesis.
引用
收藏
页码:15 / 29
页数:15
相关论文
共 77 条
[1]
ATHEROGENESIS IN DIABETES [J].
BIERMAN, EL .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (06) :647-656
[2]
Effect of leptin on arterial thrombosis following vascular injury in mice [J].
Bodary, PF ;
Westrick, RJ ;
Wickenheiser, KJ ;
Shen, YC ;
Eitzman, DT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (13) :1706-1709
[3]
Morphologic findings of coronary atherosclerotic plaques in diabetics - A postmortem study [J].
Burke, AP ;
Kolodgie, FD ;
Zieske, A ;
Fowler, DR ;
Weber, DK ;
Varghese, PJ ;
Farb, A ;
Virmani, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (07) :1266-1271
[4]
Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis [J].
Camejo, G ;
Hurt-Camejo, E ;
Wiklund, O ;
Bondjers, G .
ATHEROSCLEROSIS, 1998, 139 (02) :205-222
[5]
Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice [J].
Chen, H ;
Charlat, O ;
Tartaglia, LA ;
Woolf, EA ;
Weng, X ;
Ellis, SJ ;
Lakey, ND ;
Culpepper, J ;
Moore, KJ ;
Breitbart, RE ;
Duyk, GM ;
Tepper, RI ;
Morgenstern, JP .
CELL, 1996, 84 (03) :491-495
[6]
Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice [J].
Collins, AR ;
Meehan, WP ;
Kintscher, U ;
Jackson, S ;
Wakino, S ;
Noh, G ;
Palinski, W ;
Hsueh, WA ;
Law, RE .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) :365-371
[7]
Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet [J].
Dixon, JL ;
Stoops, JD ;
Parker, JL ;
Laughlin, MH ;
Weisman, GA ;
Sturek, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) :2981-2992
[8]
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis [J].
Forbes, JM ;
Yee, LTL ;
Thallas, V ;
Lassila, M ;
Candido, R ;
Jandeleit-Dahm, KA ;
Thomas, MC ;
Burns, WC ;
Deemer, EK ;
Thorpe, SM ;
Cooper, ME ;
Allen, TJ .
DIABETES, 2004, 53 (07) :1813-1823
[9]
Are predictors of coronary heart disease and lower-extremity arterial disease in type I diabetes the same? A prospective study [J].
Forrest, KYZ ;
Becker, DJ ;
Kuller, LH ;
Wolfson, SK ;
Orchard, TJ .
ATHEROSCLEROSIS, 2000, 148 (01) :159-169
[10]
Leptin and the regulation of body weight in mammals [J].
Friedman, JM ;
Halaas, JL .
NATURE, 1998, 395 (6704) :763-770